FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


19439 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Metaproterenol 20mg tablet Orciprenaline sulfate 20 mg oral tablet
Metaproterenol sulfate 0.65mg/inh aerosol Orciprenaline only product in pulmonary dose form
Metaproterenol sulfate 15mg/mL aerosol Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Metastasis stage M1a American Joint Committee on Cancer cM1a (qualifier value)
Metastasis stage M1b American Joint Committee on Cancer cM1b (qualifier value)
Metastasis stage M1c cM1c
Metastasis stage M2 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M3 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M4 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage pM1 American Joint Committee on Cancer pM1 (qualifier value)
Metastasizing pleomorphic adenoma Pleomorphic adenoma
Metastatic apocrine adenocarcinoma to skin Metastatic apocrine adenocarcinoma (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (morphologic abnormality)
Metastatic carcinoma to female breast Metastatic carcinoma to breast
Metastatic carcinoma to male breast Metastatic carcinoma to breast
Metastatic cholangiocarcinoma to biliary tract Metastatic cholangiocarcinoma (morphologic abnormality)
Metastatic cholangiocarcinoma to perihilar bile duct Metastatic cholangiocarcinoma
Metastatic collecting duct carcinoma to kidney Metastatic collecting duct renal cell carcinoma (disorder)
Metastatic cystic renal cell carcinoma to kidney Metastatic cystic renal cell carcinoma
Metastatic eccrine porocarcinoma to skin Metastatic eccrine porocarcinoma
Metastatic infiltrating duct carcinoma to female breast Metastatic infiltrating duct carcinoma to breast (disorder)
Metastatic lobular carcinoma to breast Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to left female breast Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to right female breast Metastatic lobular carcinoma (disorder)
Metastatic malignant neoplasm to areola of female breast Metastatic malignant neoplasm to areola (disorder)
Metastatic malignant neoplasm to areola of male breast Metastatic malignant neoplasm to areola (disorder)
Metastatic malignant neoplasm to axillary tail of female breast Metastatic malignant neoplasm to axillary tail of breast (disorder)
Metastatic malignant neoplasm to central portion of female breast Metastatic malignant neoplasm to central portion of breast (disorder)
Metastatic malignant neoplasm to colon and/or rectum Metastatic malignant neoplasm to cecum and/or colon and/or rectum (disorder)
Metastatic malignant neoplasm to ectopic female breast tissue Metastatic malignant neoplasm to ectopic site of breast (disorder)
Metastatic malignant neoplasm to ectopic male breast tissue Metastatic malignant neoplasm to ectopic site of breast (disorder)
Metastatic malignant neoplasm to female breast Metastatic malignant neoplasm to breast (disorder)
Metastatic malignant neoplasm to lower inner quadrant of female breast Metastatic malignant neoplasm to lower inner quadrant of breast (disorder)
Metastatic malignant neoplasm to lower outer quadrant of female breast Metastatic malignant neoplasm to lower outer quadrant of breast
Metastatic malignant neoplasm to lymph node from primary malignant neoplasm of female breast Metastatic malignant neoplasm to lymph node
Metastatic malignant neoplasm to male breast Metastatic malignant neoplasm to breast (disorder)
Metastatic malignant neoplasm to nipple of female breast Metastatic malignant neoplasm to nipple (disorder)
Metastatic malignant neoplasm to nipple of male breast Metastatic malignant neoplasm to nipple (disorder)
Metastatic malignant neoplasm to upper inner quadrant of female breast Metastatic malignant neoplasm to upper inner quadrant of breast
Metastatic malignant neoplasm to upper outer quadrant of female breast Metastatic malignant neoplasm to upper outer quadrant of breast (disorder)
Metastatic pilomatrix carcinoma to skin Metastatic pilomatrix carcinoma (disorder)
Metastatic renal cell carcinoma to kidney Metastatic renal cell carcinoma
Metastatic renal cell carcinoma to kidney except renal pelvis Metastatic renal cell carcinoma
Metatarsal phalangeal joint flap Flap (substance)
Methacholine 2.5% eye drops Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug)
Methacholine chloride 100mg powder Product containing only methacholine (medicinal product)
Methadone 10mg/5mL mixture Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Methadone hydrochloride 40mg dispersible tablet Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Methamphetamine hydrochloride 10mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 10mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methicillin resistant staphylococcus aureus as the cause of diseases classified to other chapters Methicillin resistant Staphylococcus aureus infection (disorder)
Methicillin resistant staphylococcus aureus as the cause of diseases classified to other chapters Methicillin resistant Staphylococcus aureus infection (disorder)
Method of delivery NOS Delivery procedure
Method of delivery NOS Delivery procedure
Methods of operation NOC Surgical procedure (procedure)
Methods of operation NOC NOS Surgical procedure (procedure)
Methohexital sodium 5g powder for injection solution vial Product containing only methohexital (medicinal product)
Methoxsalen 20mcg/mL injection solution 10mL vial Methoxsalen 20 microgram/mL solution for injection
Methyl aminolevulinate 168mg/g topical cream Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream
Methyl methacrylate embolism Foreign body embolus
Methyl parathion Hexaethyl tetraphosphate
Methylcellulose 1% eye drops Methylcellulose 10 mg/mL eye solution
Methylcitrate 2-methylcitrate (substance)
Methylcitrate measurement 2-methylcitrate measurement (procedure)
Methylene blue 1% injection solution vial Methylthioninium chloride only product in parenteral dose form
Methylene blue 65mg tablet Methylthioninium chloride 65 mg oral tablet
Methylenedioxymethamphetamine dependence with current use Methylenedioxymethamphetamine dependence
Methylobacterium animovorans Methylorubrum aminovorans
Methylobacterium lusitanum Methylorubrum rhodesianum
Methylphenidate 10mg chewable tablet Methylphenidate hydrochloride 10 mg chewable tablet
Methylphenidate 2.5mg chewable tablet Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug)
Methylphenidate 5mg chewable tablet Methylphenidate hydrochloride 5 mg chewable tablet
Methylphenidate hydrochloride 10mg m/r tablet Product containing only methylphenidate in oral dose form (medicinal product form)
Methylphenidate hydrochloride 10mg prolonged-release oral tablet Product containing only methylphenidate in oral dose form (medicinal product form)
Methylphenidate hydrochloride 72mg m/r tablet Product containing only methylphenidate in oral dose form (medicinal product form)
Methylphenidate hydrochloride 72mg prolonged-release oral tablet Product containing only methylphenidate in oral dose form (medicinal product form)
Methylprednisolone 125mg powder and solvent for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone 1g powder and solvent for injection solution vial Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone 2g powder and solvent for injection solution vial Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone 40mg powder and solvent for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Methylprednisolone 500mg powder and solvent for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial
Methylprednisolone sodium su 1000mg/8mL injection Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone sodium su 125mg injection Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone sodium su 125mg/2mL powder Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone sodium su 125mg/vial powder for injection Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone sodium su 1g/vial injection Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone sodium su 40mg powder Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Methylprednisolone sodium su 40mg/mL powder Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Methylprednisolone sodium su 500mg/4mL injection Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial
Methylprednisolone sodium succinate 125mg powder for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone sodium succinate 1g powder for injection solution vial Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone sodium succinate 2g powder for injection solution vial Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone sodium succinate 40mg powder for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Methylprednisolone sodium succinate 500g powder for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial
Methylprednisolone sodium succinate 500mg powder for injection solution vial Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial
Methyltetrahydrophtalic anhydrid specific extract Methyltetrahydrophtalic anhydride

Start Previous Page 98 of 195 Next End


Reference Sets

Reference set descriptor

Back to Start